CRCM  Vol.3 No.5 , May 2014
Case Report: Normocalcemic Hyperparathyroidism
Abstract: A case of normocalcemic hyperparathyroidism is diagnosed basing on the clinical manifestations & laborotary investigation supported by finding of unilateral parathyroid adenoma on imaging studies and the patient was referred for surgical exploration for the parathyroid adenoma.
Cite this paper: Muhammed Mustafa, H. , Al Shekhani, M. and Jamal, B. (2014) Case Report: Normocalcemic Hyperparathyroidism. Case Reports in Clinical Medicine, 3, 253-256. doi: 10.4236/crcm.2014.35058.


[2]   Díaz-Soto, G., Julián, M.T. and Puig-Domingo, M. (2012) Normocalcemic Primary Hyperparathyroidism: A Newly Emerging Disease Needing Therapeutic Intervention. Hormones (Athens), 11, 390-396.

[3]   Koumakis, E., Souberbielle, J.C., Sarfati, E., Meunier, M., Maury, E., Gallimard, E., et al. (2013) Bone Mineral Density Evolution after Successful Parathyroidectomy in Patients with Normocalcemic Primary Hyperparathyroidism. The Journal of Clinical Endocrinology and Metabolism, 98, 3213-3220.

[4]   Gupta, V. (2013) Normocalcemic Primary Hyperparathyroidism in a Patient with Severe Osteoporosis Receiving Teriparatide. Indian Journal of Endocrinology and Metabolism, 17, 336-338.

[5]   Cusano, N.E., Maalouf, N.M., Wang, P.Y., Zhang, C., Cremers, S.C., Haney, E.M., et al. (2013) Normocalcemic Hyperparathyroidism and Hypoparathyroidism in Two Community-Based Nonreferral Populations. The Journal of Clinical Endocrinology and Metabolism, 98, 2734-2741.

[6]   Martínez Díaz-Guerra, G., Jódar Gimeno, E., Reyes García, R., Gómez Sáez, J.M., Muñoz-Torres, M., et al. (2013) Normocalcemic Primary Hyperparathyroidism: Recommendations for Management and Follow-up. Endocrinological Nutrition, 60, e1-e6.

[7]   Bilezikian, J.P. and Silverberg, S. (2010) Normocalcemic Primary Hyperparathyroidism. Arq Bras Endocrinological Metabology, 54, 106-109.

[8]   Tachibana, S., Yokoi, T., Sato, S., Yanase, T. and Yamashita, H. (2013) Surgically Proven Normocalcemic Primary Hyperparathyroidism: Speculation of the Possible Role of Estrogen in the Etiology of This Disease in Premenopausal Women. Internal Medicine, 52, 781-785.

[9]   Cusano, N.E., Silverberg, S.J. and Bilezikian, J.P. (2013) Normocalcemic Primary Hyperparathyroidism. Journal of Clinical Densitometry, 16, 33-39.

[10]   Lewiecki, E.M. and Miller, P.D. (2013) Skeletal Effects of Primary Hyperparathyroidism: Bone Mineral Density and Fracture Risk. Journal of Clinical Densitometry, 16, 28-32.

[11]   Grønli, O. and Wynn, R. (2013) Normocalcemic Hyperparathyroidism and Treatment Resistant Depression. Psychosomatics, 54, 493-497.

[12]   Misiorowski, W. and Zgliczyński, W. (2012) Prevalence of Primary Hyperparathyroidism among Patients with Low Bone Mass. Advances in Medical Sciences, 57, 308-313.

[13]   Saliba, W., Lavi, I., Rennert, H.S. and Rennert, G. (2013) The Evaluation of Vitamin D Status in Normocalcemic Primary Hyperparathyroidism. European Journal of Internal Medicine, 24, e8.

[14]   Martínez Díaz-Guerra, G., Guadalix Iglesias, S. and Hawkins Carranza, F. (2013) Normocalcemic Primary Hyperparathyroidism: A Growing Problem. Medicina Clínica (Barc), 141, 125-129.